There are 2789 resources available
1348P - Long-term survival and health-related quality of life with nivolumab for previously-treated advanced non-small cell lung cancer (NSCLC): A wide prospective French real-world study (EVIDENS)
Presenter: Fabrice Barlesi
Session: ePoster Display
1349P - Application of a classifier combining bronchial transcriptomics and chest CT features facilitates the diagnostic evaluation of lung cancer in smokers and non-smokers
Presenter: Wen Li
Session: ePoster Display
Resources:
Abstract
1350P - Characteristics, treatment patterns and outcome of non-small cell lung cancer (NSCLC) patients presenting with brain-only metastatic disease
Presenter: Amir Sabouhanian
Session: ePoster Display
1352P - A highly predictive blood-radiomics classifier in advanced NSCLC treated with immunotherapy
Presenter: Giulia Mazzaschi
Session: ePoster Display
1353P - Similarities and differences in the spatial distribution of brain metastases in small cell lung cancer and non-small cell lung cancer: Quantitative analysis and identifying metastatic risk region may be helpful for the whole-brain radiotherapy with non-uniform dose prescriptions
Presenter: Rongjie Tao
Session: ePoster Display
Resources:
Abstract
1354P - Comparison of different hyperprogressive disease criteria in non-small cell lung cancer patients treated with immunotherapy and correlation with somatic mutations in driver genes
Presenter: Miren Zuazo
Session: ePoster Display
Resources:
Abstract
1355P - Monitoring tumor growth rate to predict immune checkpoint inhibitors’ treatment outcome in advanced NSCLC
Presenter: Filippo Dall'Olio
Session: ePoster Display
1432P - Characterizing diversity in the immune profile by a transcriptomic customized gene signature to potentially personalize treatment in advanced gastric cancer patients
Presenter: Manuel Cabeza-Segura
Session: ePoster Display
1433P - Esophageal cancer cell dynamics significantly depended on blood cell circuit, biochemical factors, hemostasis system, cancer characteristics and anthropometric data
Presenter: Oleg Kshivets
Session: ePoster Display
1434TiP - MOUNTAINEER-02: Phase II/III study of tucatinib, trastuzumab, ramucirumab, and paclitaxel in previously treated HER2+ gastric or gastroesophageal junction adenocarcinoma (GEC): Trial in progress
Presenter: Daniel Catenacci
Session: ePoster Display